# Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

> **NCT02926651** · PHASE4 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Anemia
- Arthritis
- Total Knee Arthroplasty
- Total Hip Arthroplasty

## Interventions

- **DRUG:** Conventional Oral TXA (Tranexamic Acid)
- **DRUG:** Multi-Dose Oral TXA (Tranexamic Acid)

## Key facts

- **NCT ID:** NCT02926651
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-10
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02926651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02926651, "Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02926651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*